Axcelis Technologies, Inc. designs, manufactures and services the ion implantation and other processing equipment used in the manufacture of semiconductor chips in the United States, Europe and Asia. The company is headquartered in Beverly, Massachusetts.
| Revenue (TTM) | $866.07M |
| Gross Profit (TTM) | $372.51M |
| EBITDA | $99.39M |
| Operating Margin | 9.43% |
| Return on Equity | 8.89% |
| Return on Assets | 4.12% |
| Revenue/Share (TTM) | $28.00 |
| Book Value | $34.51 |
| Price-to-Book | 3.35 |
| Price-to-Sales (TTM) | 3.86 |
| EV/Revenue | 3.708 |
| EV/EBITDA | 24.89 |
| Quarterly Earnings Growth (YoY) | -23.50% |
| Quarterly Revenue Growth (YoY) | 10.60% |
| Shares Outstanding | $30.88M |
| Float | $30.69M |
| % Insiders | 0.68% |
| % Institutions | 103.63% |
Volatility is currently contracting
In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $142.31, denoting a -3.69% move from the preceding trading day.
BEVERLY, Mass., Sept. 21, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be participating in the 23rd International Conference on Silicon Carbide and Related Materials (ICSCRM 2026) taking place September 28 - October 2, 2026, at the Pacifico Yokohama North in Japan.
Axcelis Technologies (ACLS) concluded the recent trading session at $103.75, signifying a -1.23% move from its prior day's close.
Axcelis shares fell 22.4% in a month as recovering bookings and demand collide with weaker margins, backlog pressure and heavy China exposure.
Axcelis plans a $35M South Korea ion implantation facility to expand Asian capacity as memory, power and mature-node activity improves.
Axcelis growth is returning as memory, power and aftermarket demand improve, but premium valuation and incomplete margin recovery keep execution in focus.
BEVERLY, Mass., Sept. 14, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, will be a Platinum Sponsor at the International Conference on Ion Implantation and Annealing Technology 2026 (IIT 2026) taking place September 20-24 at the Congress Center Villach in Austria.
BEVERLY, Mass., Sept. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced plans to invest $35 million in its global manufacturing infrastructure through the construction of a new ion implantation equipment manufacturing facility in Pyeongtaek, Gyeonggi Province, Korea.
BEVERLY, Mass., Sept. 1, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences: The Citi 2026 Global TMT Conference on Tuesday, September 8th at the New York Hilton Midtown.
Investors need to pay close attention to ACLS stock based on the movements in the options market lately.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACLS and any ticker you trade — then tracks every position and per-strategy win rate.
